SavedAdd your journal

Journals / Toplum ve Hekim / 2016 / Cilt: 31 - Sayı: 1

Chronic Pain and Access to Treatment at the End of Life

HAYATIN SON DÖNEMİNDE KRONİK AĞRI VE TEDAVİYE ERİŞİM

Meltem UYAR
Halil ÇETİNGÖK
N.Süleyman ÖZYALÇIN
Pages
18–24
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We should mention especially the opiophobia and lack of palliative care system among them.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The most important subject which aff ects the quality of life is chronic pain at the end of life especially for cancer patients.
📊
Key Findings & Data:The World Health Organization analgesic ladder for eff ective treatment of cancer pain has been the main guide from 1986 to nowadays worldwide.
💡
Conclusion & Impact:We should mention especially the opiophobia and lack of palliative care system among them.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The most important subject which aff ects the quality of life is chronic pain at the end of life especially for cancer patients. The World Health Organization analgesic ladder for eff ective treatment of cancer pain has been the main guide from 1986 to nowadays worldwide. Nevertheless there are a lot of diff iculties (be drived from medical doctors and health employees, patients and care givers, health care system) to access enough pain treatment for the cancer patients in our country. We should mention especially the opiophobia and lack of palliative care system among them.

Özet

Başta kanser hastaları olmak üzere hayatın son döneminde hayat kalitesini etkileyen en önemli konu kronik ağrılardır. Dünya Sağlık Örgütü tarafından 1986 yılında ortaya atılan basamak modeli yaklaşımı o yıllardan bu yana kanser ağrısının tüm dünyada etkili bir şekilde sağaltımında ana kılavuz olmuştur. Buna karşın ülkemizde genel olarak hekimler ve sağlık çalışanları, hastalar ve yakın çevreleri ile sağlık sisteminden kaynaklanan çeşitli sorunlar kanser hastalarının yeterli ağrı tedavisine erişimleri önünde engel oluşturmaktadır. Bunlar arasında özellikle opiyofobi ve palyatif bakım sistemindeki eksikliklerden bahsetmemiz gerekir.

🔖

Cite This Article

UYAR, M., ÇETİNGÖK, H., ÖZYALÇIN, N. (2016). Chronic Pain and Access to Treatment at the End of Life. Toplum ve Hekim, Cilt: 31 - Sayı: 1, 18–24. https://ajindex.com/articles/367464

References (15)

  1. ATOME (2013) Mevzuat İncelemesi Türkiye Ülke Raporu. Opi- oid ilaçların erişilebilirliğini ve bulunabilirliğini artırmaya yö- nelik mevzuat önerileri, 2013.
  2. Breivik H, Cherny, N., Collett, F. (2009) Cancer-related pain: a pan European survey of prevalence, treatment, and patient at- titudes. Ann Oncol, 20, 1420-33.
  3. Cleary, J, Silbermann, M., Scholten,W., Radbruch, L., Toro- deJ, Cherny N.I. (2013) Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in the Middle East: a report from the Global Opioid Policy Initiative (GOPI). Annals of Oncology 24 (Supplement 11): xi51-xi59,. Coyle, N, Layman-Goldstein, M. (2007) Pharmacologic man- agement of adult cancer pain. Oncology (Williston Park), 21(2): 22. Davis, M.P.,Walsh, D. (2004) Epidemiology of cancer pain and factors infl uencing poor pain control.AmJ Hosp Palliat Care:137-42,.
  4. Komurcu, S. (2011) Current Status of Palliative Care in Turkey. J Pediatr Hematol Oncol, 33, (1), (1):S78-80 Meier DE. (2006) Palliative care in hospitals. J Hosp Med. Jan;1(1): 21-8.
  5. Manjiani, D., Paul, D.B., Kunnumpurath, S., Kaye AD, Vadivelv, N. (2014) Availability and Utilization of Opioids for Pain Management: Global Issues. Th e Ochsner Journal 14:208-215,.
  6. Massie, MJ. (2004) Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr, (32):57-71.
  7. Özgül, N., Koç, O., Gültekin, M. (2012) Opioids for Cancer pain:Availability,Accessibility and Regulatory Barriers in Turkey and Pallia-Turk Project, Annals of Oncology, 23: 72-4.
  8. Pirl, W.F. (2004) Evidence report on the occurrence, assessment, and treatment of depression in cancer patients. J Natl Cancer Inst Monogr (32):32-9.
  9. Reid, C.M., Forbes, K. (2007) Pain in patients with cancer: still a long way to go. Pain 132:229-30.
  10. Ripamonti CI, Bandieri, E., Roila, F; (2011) ESMO Guidelines Working Group. Management of cancer pain: ESMO Clinical Practice Guidelines.Ann Oncol, 22 (6): 69-77.
  11. Rise, A.S. (2008) Clinical pain management (2nd edition). Ethical issues in cancer pain management: 93-99.
  12. Sağlık Bakanlığı (1985) 5768 numaralı Kontrola tabi uyuşturucu madde ve müstahzarların reçeteleri hakkında genelge, Tarih: 29.5.1985.
  13. Sağlık Bakanlığı (1986) 2677 numaralı Psikotrop ilaç reçeteleri hakkında genelge, Tarih: 2.1.1986.
  14. University of Wisconsin-Madison, Pain Policy Studies Group: Improving global pain relief by achieving balanced access to opioids worldwide, reports in 2013.
  15. Van den Beuken-van Everdingen M.H.J., De Rijke JM, Kesse